299 related articles for article (PubMed ID: 17764095)
1. HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?
Howard K; Salkeld G; McCaffery K; Irwig L
Health Econ; 2008 May; 17(5):593-605. PubMed ID: 17764095
[TBL] [Abstract][Full Text] [Related]
2. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
Apgar BS; Brotzman G
Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
[TBL] [Abstract][Full Text] [Related]
3. HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice.
McCaffery KJ; Irwig L; Chan SF; Macaskill P; Barratt A; Lewicka M; Clarke J; Weisberg E
Patient Educ Couns; 2008 Dec; 73(3):473-9, 481. PubMed ID: 18757164
[TBL] [Abstract][Full Text] [Related]
4. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
Layfield LJ; Qureshi MN
Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
6. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
7. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
8. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
9. [Colposcopic-histologic results in 97 patients with mild dysplasia shown by Pap test].
Crescini C; Pezzica E; Artuso A; Comerio D; Reale D; Bonaldi A
Minerva Ginecol; 1991 Nov; 43(11):509-12. PubMed ID: 1784407
[TBL] [Abstract][Full Text] [Related]
10. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
12. A cost-effectiveness analysis of four management strategies in the determination and follow-up of atypical squamous cells of undetermined significance.
Hughes AA; Glazner J; Barton P; Shlay JC
Diagn Cytopathol; 2005 Feb; 32(2):125-32. PubMed ID: 15637677
[TBL] [Abstract][Full Text] [Related]
13. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
Tayyeb R; Khawaja NP; Malik N
J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
[TBL] [Abstract][Full Text] [Related]
14. The role of HPV testing in patients with possible high-grade cervical cytology.
Rao A; Pather S; Dalrymple C; Mackie A; Deans R; Carter J
J Obstet Gynaecol Res; 2009 Jun; 35(3):503-6. PubMed ID: 19527390
[TBL] [Abstract][Full Text] [Related]
15. Management of the low-grade abnormal Pap smear: What are women's preferences?
Melnikow J; Kuppermann M; Birch S; Chan BK; Nuovo J
J Fam Pract; 2002 Oct; 51(10):849-55. PubMed ID: 12401153
[TBL] [Abstract][Full Text] [Related]
16. Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility.
Birch S; Melnikow J; Kuppermann M
Health Econ; 2003 Oct; 12(10):879-84. PubMed ID: 14508872
[TBL] [Abstract][Full Text] [Related]
17. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
Sharpless KE; O'Sullivan DM; Schnatz PF
J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial impact of inclusion of HPV test on the management of women with atypical squamous cells of undetermined significance: a study within a randomised pragmatic trial in a middle-income country.
Garcés-Palacio IC; Sanchez GI; Baena Zapata A; Córdoba Sánchez V; Urrea Cosme Y; Rodríguez Zabala D; Ruiz Osorio MA
Psychol Health; 2020 Jun; 35(6):750-769. PubMed ID: 31625399
[No Abstract] [Full Text] [Related]
19. [Significance of human papillomavirus test in triage of patients with atypical squamous cell of undetermined significance].
Zhao J; Zhou JN; Yang YJ; Liao QP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):299-301. PubMed ID: 19105350
[TBL] [Abstract][Full Text] [Related]
20. A decision analysis of practice patterns used in evaluating and treating abnormal Pap smears.
Roland PY; Naumann RW; Alvarez RD; Kilgore LC; Partridge EE
Gynecol Oncol; 1995 Oct; 59(1):75-80. PubMed ID: 7557619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
